Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Duffy

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|June 22, 2011
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single centerJohnny C Hong, Christopher M Jones, John P Duffy, et al.
Annals of Surgery|October 1, 2010
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivorsJohn P Duffy, Kenneth Kao, Clifford Y Ko, et al.
Annals of Surgery|August 25, 2007
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLAJohn P Duffy, Andrew Vardanian, Elizabeth Benjamin, et al.
Oncotarget|February 9, 2018
Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancerDavid Onion, Mark Isherwood, Naveen Shridhar, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2009
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2Mark W Ledeboer, Albert C Pierce, John P Duffy, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of VX-745: A Novel and Selective p38α Kinase InhibitorJohn P Duffy, Edmund M Harrington, Francesco G Salituro, et al.
Journal of Medicinal Chemistry|December 18, 2009
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindoleTiansheng Wang, John P Duffy, Jian Wang, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of Medicinal Chemistry|December 6, 2021
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1Michael J Boyd, Philip N Collier, Michael P Clark, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Archives of Surgery (Chicago, Ill. : 1960)|June 22, 2011
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single centerJohnny C Hong, Christopher M Jones, John P Duffy, et al.
Annals of Surgery|October 1, 2010
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivorsJohn P Duffy, Kenneth Kao, Clifford Y Ko, et al.
Annals of Surgery|August 25, 2007
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLAJohn P Duffy, Andrew Vardanian, Elizabeth Benjamin, et al.
Oncotarget|February 9, 2018
Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancerDavid Onion, Mark Isherwood, Naveen Shridhar, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2009
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2Mark W Ledeboer, Albert C Pierce, John P Duffy, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of VX-745: A Novel and Selective p38α Kinase InhibitorJohn P Duffy, Edmund M Harrington, Francesco G Salituro, et al.
Journal of Medicinal Chemistry|December 18, 2009
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindoleTiansheng Wang, John P Duffy, Jian Wang, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of Medicinal Chemistry|December 6, 2021
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1Michael J Boyd, Philip N Collier, Michael P Clark, et al.
Pageof 6